---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-023768"
form_type: "8-K"
ticker: "CLDX"
cik: "0000744218"
company_name: "Celldex Therapeutics, Inc."
filed_at: "2023-02-21T23:59:59+00:00"
generated_at: "2026-06-19T07:30:00.722362+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Celldex appoints Rita Jain, M.D. to Board of Directors

## Summary
- Rita Jain, M.D. appointed to Celldex Board effective February 16, 2023.
- Dr. Jain receives initial option grant for 17,100 shares vesting over three years.
- She previously served as CMO of ChemoCentryx and Immunovant, and SVP/CMO at Akebia.
- Dr. Jain currently serves on boards of Provention Bio and AM Pharma supervisory board.
- Appointment fills board vacancy; no family relationships or material transactions disclosed.

## SEC filing metadata
- accession: 0001104659-23-023768
- form_type: 8-K
- ticker: CLDX
- cik: 0000744218
- company_name: Celldex Therapeutics, Inc.
- filed_at: 2023-02-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744218/000110465923023768/0001104659-23-023768-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744218/000110465923023768/tm237425d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-023768
- JSON: https://secwatch.observer/filing/0001104659-23-023768.json
- Plain text: https://secwatch.observer/filing/0001104659-23-023768.txt

## Key facts
- Executive change
  Rita Jain, M.D. was appointed as member of the Board of Directors at Celldex Therapeutics, Inc..
  - Action: appointed
  - Role: member of the Board of Directors
  source text: Rita Jain, M.D. was appointed as a member of our Board of Directors (the “ Board ”) on February 16, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/744218/000110465923023768/0001104659-23-023768-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.